100 related articles for article (PubMed ID: 37715442)
21. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea.
Fujihara T; Hayashi K
Arch Virol; 1995; 140(8):1469-72. PubMed ID: 7661698
[TBL] [Abstract][Full Text] [Related]
22. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
23. Genome-Wide CRISPR Screen Identifies RACK1 as a Critical Host Factor for Flavivirus Replication.
Shue B; Chiramel AI; Cerikan B; To TH; Frölich S; Pederson SM; Kirby EN; Eyre NS; Bartenschlager RFW; Best SM; Beard MR
J Virol; 2021 Nov; 95(24):e0059621. PubMed ID: 34586867
[TBL] [Abstract][Full Text] [Related]
24. Hypericin blocks the function of HSV-1 alkaline nuclease and suppresses viral replication.
Cao K; Zhang Y; Yao Q; Peng Y; Pan Q; Jiao Q; Ren K; Sun F; Zhang Q; Guo R; Zhang J; Chen T
J Ethnopharmacol; 2022 Oct; 296():115524. PubMed ID: 35811028
[TBL] [Abstract][Full Text] [Related]
25. Short hairpin RNA-mediated inhibition of HSV-1 gene expression and function during HSV-1 infection in Vero cells.
Liu YY; Deng HY; Yang G; Jiang WL; Grossin L; Yang ZQ
Acta Pharmacol Sin; 2008 Aug; 29(8):975-82. PubMed ID: 18664330
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.
Piret J; Lamontagne J; Bestman-Smith J; Roy S; Gourde P; Désormeaux A; Omar RF; Juhász J; Bergeron MG
J Clin Microbiol; 2000 Jan; 38(1):110-9. PubMed ID: 10618073
[TBL] [Abstract][Full Text] [Related]
27. Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0.
Moriuchi H; Moriuchi M; Smith HA; Straus SE; Cohen JI
J Virol; 1992 Dec; 66(12):7303-8. PubMed ID: 1366099
[TBL] [Abstract][Full Text] [Related]
28. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas9-Based Genome Editing of HSV.
Velusamy T; Gowripalan A; Tscharke DC
Methods Mol Biol; 2020; 2060():169-183. PubMed ID: 31617178
[TBL] [Abstract][Full Text] [Related]
30. Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes.
Tanaka M; Kodaira H; Nishiyama Y; Sata T; Kawaguchi Y
Microbes Infect; 2004 Apr; 6(5):485-93. PubMed ID: 15109964
[TBL] [Abstract][Full Text] [Related]
31. The interferon-inducible protein TDRD7 inhibits AMP-activated protein kinase and thereby restricts autophagy-independent virus replication.
Subramanian G; Popli S; Chakravarty S; Taylor RT; Chakravarti R; Chattopadhyay S
J Biol Chem; 2020 May; 295(20):6811-6822. PubMed ID: 32273341
[TBL] [Abstract][Full Text] [Related]
32. The Mutation of the Genes Related to Neurovirulence in HSV-2 Produces an Attenuated Phenotype in Mice.
Liu L; Cheng J; Mou T; Zhang Y; Xu X; Zhang J; Li X; Feng X; Xu X; Liao Y; Fan S; Wang L; Jiang G; Li Q
Viruses; 2020 Jul; 12(7):. PubMed ID: 32708847
[TBL] [Abstract][Full Text] [Related]
33. From functional genomics of vero cells to CRISPR-based genomic deletion for improved viral production rates.
Sène MA; Xia Y; Kamen AA
Biotechnol Bioeng; 2022 Oct; 119(10):2794-2805. PubMed ID: 35869699
[TBL] [Abstract][Full Text] [Related]
34. [Anti-herpes simplex virus type Ⅰ of tectorigenin derivative and effect on Toll-like receptors in vitro].
Wang Y; Yuan MM; Zhou J; Zheng XH; Yuan CJ; Chen S; Luo S; Zhang L
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4428-4435. PubMed ID: 36046872
[TBL] [Abstract][Full Text] [Related]
35. Phosphoregulation of a Conserved Herpesvirus Tegument Protein by a Virally Encoded Protein Kinase in Viral Pathogenicity and Potential Linkage between Its Evolution and Viral Phylogeny.
Shibazaki M; Kato A; Takeshima K; Ito J; Suganami M; Koyanagi N; Maruzuru Y; Sato K; Kawaguchi Y
J Virol; 2020 Aug; 94(18):. PubMed ID: 32611749
[TBL] [Abstract][Full Text] [Related]
36. The chicken chorioallantoic membrane model for isolation of CRISPR/cas9-based HSV-1 mutant expressing tumor suppressor p53.
Kelishadi M; Shahsavarani H; Tabarraei A; Shokrgozar MA; Teimoori-Toolabi L; Azadmanesh K
PLoS One; 2023; 18(10):e0286231. PubMed ID: 37862369
[TBL] [Abstract][Full Text] [Related]
37. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated RNA interference against herpes simplex virus infection in vitro.
Chen L; Pan ZQ; Zhai CB
Folia Histochem Cytobiol; 2021; 59(4):302-310. PubMed ID: 34905214
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated shRNA interference against HSV-1 replication in vitro.
Song B; Liu X; Wang Q; Zhang R; Yang T; Han Z; Xu Y
J Neurovirol; 2016 Dec; 22(6):799-807. PubMed ID: 27566181
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
